The Murine Antitumor Immune Response and Its Therapeutic Manipulation
- 1 January 1984
- book chapter
- Published by Elsevier
- Vol. 35, 89-155
- https://doi.org/10.1016/s0065-2776(08)60575-1
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity.The Journal of Experimental Medicine, 1984
- The T lymphocyte antigen receptor—paradigm lostNature, 1982
- CELLS MEDIATING GRAFT REJECTION IN THE MOUSETransplantation, 1982
- T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.The Journal of Experimental Medicine, 1981
- Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression.The Journal of Experimental Medicine, 1981
- T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu miceNature, 1980
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity.The Journal of Experimental Medicine, 1978
- ADOPTIVE CHEMOIMMUNOTHERAPY OF CANCER IN ANIMALS: A REVIEW OF RESULTS, PRINCIPLES, AND PROBLEMSAnnals of the New York Academy of Sciences, 1976
- THE THERAPEUTIC VALUE OF THE MIXED TOXINS OF THE STREPTOCOCCUS OF ERYSIPELAS AND BACILLUS PRODIGIOSUS IN THE TREATEMENT OF INOPER- ABLE MALIGNANT TUMORSThe Lancet Healthy Longevity, 1896